Therapy and clinical trials.
Publication
, Journal Article
Elmallah, W; Krasuski, RA
Published in: Curr Opin Lipidol
December 2011
Duke Scholars
Published In
Curr Opin Lipidol
DOI
EISSN
1473-6535
Publication Date
December 2011
Volume
22
Issue
6
Start / End Page
512 / 513
Location
England
Related Subject Headings
- Sulfhydryl Compounds
- Randomized Controlled Trials as Topic
- Niacin
- Hypolipidemic Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Esters
- Drug Therapy, Combination
- Diabetes Mellitus
- Coronary Artery Disease
Citation
APA
Chicago
ICMJE
MLA
NLM
Elmallah, W., & Krasuski, R. A. (2011). Therapy and clinical trials. Curr Opin Lipidol, 22(6), 512–513. https://doi.org/10.1097/MOL.0b013e32834d208d
Elmallah, Wael, and Richard A. Krasuski. “Therapy and clinical trials.” Curr Opin Lipidol 22, no. 6 (December 2011): 512–13. https://doi.org/10.1097/MOL.0b013e32834d208d.
Elmallah W, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2011 Dec;22(6):512–3.
Elmallah, Wael, and Richard A. Krasuski. “Therapy and clinical trials.” Curr Opin Lipidol, vol. 22, no. 6, Dec. 2011, pp. 512–13. Pubmed, doi:10.1097/MOL.0b013e32834d208d.
Elmallah W, Krasuski RA. Therapy and clinical trials. Curr Opin Lipidol. 2011 Dec;22(6):512–513.
Published In
Curr Opin Lipidol
DOI
EISSN
1473-6535
Publication Date
December 2011
Volume
22
Issue
6
Start / End Page
512 / 513
Location
England
Related Subject Headings
- Sulfhydryl Compounds
- Randomized Controlled Trials as Topic
- Niacin
- Hypolipidemic Agents
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Esters
- Drug Therapy, Combination
- Diabetes Mellitus
- Coronary Artery Disease